SSY Group (HK:2005) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
SSY Group Limited is excited to announce that their Nicorandil Tablets, used for treating angina, have received production and registration approval from China’s National Medical Products Administration. Following the Group’s previous success in registering Nicorandil as a bulk drug, this new advancement is communicated to shareholders and potential investors as part of the company’s commitment to updating on business progress.
For further insights into HK:2005 stock, check out TipRanks’ Stock Analysis page.
